RBC Capital lowered the firm's price target on eHealth to $3 from $9 and keeps a Sector Perform rating on the shares. The company's strong Q4 results were overshadowed by a softer-than-expected 2026 guide, with revenue coming in significantly below expectations, the analyst tells investors in a research note. The soft guidance is related to the pullback in marketing spend of a major Medicare Advantage payor as well as conservative assumptions around next year's annual enrollment period, RBC adds.
